RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Soleno Therapeutics Stock

Soleno Therapeutics Market capitalization 2024

Soleno Therapeutics Market capitalization

774.47 M USD

Ticker

SLNO

ISIN

US8342032005

WKN

A2JSTG

In 2024, Soleno Therapeutics's market cap stood at 774.47 M USD, a 866.65% increase from the 80.12 M USD market cap in the previous year.

The Soleno Therapeutics Market capitalization history

YEARMarket Capitalization (undefined USD)
2023171.74
202224.32
202196.99
2020149.74
201967.65
201842.76
201726
201617.52
201532.64
201418.55
2013-
2012-

Soleno Therapeutics Aktienanalyse

What does Soleno Therapeutics do?

Soleno Therapeutics Inc is a biopharmaceutical company focused on rare diseases and unmet medical needs. The company was founded in 1999 and is headquartered in Redwood City, California. Soleno Therapeutics develops and markets innovative therapies for patients who have previously had limited or no treatment options. Business model: Soleno Therapeutics specializes in developing therapies for rare diseases. The company takes an innovative approach and utilizes cutting-edge technologies to develop drugs that have the potential to improve the lives of affected patients. The company works closely with leading research institutions and experts in the industry and invests significantly in research and development of new therapies. The company employs a two-pronged approach, developing innovative drugs for unmet medical needs while also acquiring already approved drugs and optimizing them for new applications. Soleno Therapeutics then markets these drugs to physicians, hospitals, and patients worldwide. Segments: Soleno Therapeutics specializes in developing therapies for rare diseases, focusing on three main segments: 1. Hypophosphatasia: Hypophosphatasia is a rare metabolic disorder that leads to the accumulation of phosphate in the bones and tissues. This results in weak bones, pain, and a variety of other symptoms. Soleno Therapeutics has developed a novel enzyme replacement therapy product that aims to support bone formation and alleviate the symptoms of the disease. 2. Prader-Willi Syndrome: Prader-Willi Syndrome is a rare genetic disorder characterized by obesity, mental retardation, and hormonal imbalances. Soleno Therapeutics has developed a product that suppresses hunger, helping patients develop a normal diet and achieve a healthy weight. 3. Other indications: Soleno Therapeutics is also working on developing therapies for other rare diseases and unmet medical needs, including conditions such as hemophilia, narcolepsy, and Parkinson's. Products: Soleno Therapeutics currently offers the following products: 1. Treakisym: Treakisym is a novel enzyme replacement therapy product aimed at supporting bone formation in patients with hypophosphatasia. The medication has already been approved in Japan. 2. Solinum: Solinum is a product that suppresses hunger in patients with Prader-Willi Syndrome. The medication is currently in Phase III of clinical trials and is expected to be approved in the coming years. 3. Other products: Soleno Therapeutics also has a range of other products in the pipeline, focusing on the development of therapies for rare diseases. Conclusion: Soleno Therapeutics is an innovative biopharmaceutical company specializing in the development of therapies for rare diseases and unmet medical needs. The company invests significantly in research and development of new medications and works closely with industry experts. Soleno Therapeutics has already launched an enzyme replacement therapy product for hypophosphatasia and is currently working on the approval of a hunger suppressant product for Prader-Willi Syndrome. The company also has a range of other medications in the pipeline, aiming to improve the lives of patients with rare diseases. Soleno Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Market capitalization Details

Exploring Soleno Therapeutics's Market Capitalization

Soleno Therapeutics's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Soleno Therapeutics's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Soleno Therapeutics's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Soleno Therapeutics’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Soleno Therapeutics stock

What is the current Soleno Therapeutics market capitalization?

The current market capitalization of Soleno Therapeutics is 774.47 M USD.

What is market capitalization?

The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Soleno Therapeutics.

How has the market capitalization of Soleno Therapeutics developed in recent years?

The market capitalization of Soleno Therapeutics has increased/decreased by 866.65% compared to the previous year.

What does market capitalization mean for investors?

The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.

Why is market capitalization an important indicator for investors?

The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.

Why does the market capitalization fluctuate?

The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.

What role does market capitalization play in the valuation of Soleno Therapeutics?

In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.

Does the market capitalization influence the performance of Soleno Therapeutics?

There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

Does the market capitalization of Soleno Therapeutics have an influence on indices?

Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).

How much dividend does Soleno Therapeutics pay?

Over the past 12 months, Soleno Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Soleno Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Soleno Therapeutics?

The current dividend yield of Soleno Therapeutics is .

When does Soleno Therapeutics pay dividends?

Soleno Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Soleno Therapeutics?

Soleno Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Soleno Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Soleno Therapeutics located?

Soleno Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Soleno Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Soleno Therapeutics from 7/23/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/23/2024.

When did Soleno Therapeutics pay the last dividend?

The last dividend was paid out on 7/23/2024.

What was the dividend of Soleno Therapeutics in the year 2023?

In the year 2023, Soleno Therapeutics distributed 0 USD as dividends.

In which currency does Soleno Therapeutics pay out the dividend?

The dividends of Soleno Therapeutics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Soleno Therapeutics

Our stock analysis for Soleno Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Soleno Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.